Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug

| From
Photo: Comfortear Lacrisolve

PORTLAND, Ore., Nov. 17, 2014 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear® Lacrisolve™ Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.

"Receiving FDA 510(k) clearance for this device was an important milestone for Paragon. Now receiving the CE mark approval will allow additional commercialization throughout the European Union. In keeping with Paragon's ultimate goal to protect and preserve eyesight, the Comfortear® Lacrisolve™ Absorbable Punctum Plug is a great addition to our portfolio of ophthalmic products," said Lauren M-C Bluett, Director of Quality Assurance.

About Comfortear® Lacrisolve™ Absorbable Punctum Plug:

Comprised of the synthetic absorbable polymer, polydioxanone, the Comfortear® Lacrisolve™ Absorbable Punctum Plugs are medium-term implants designed to be inserted into the canaliculus in order to block tear drainage through the lacrimal drainage system. The Comfortear® Lacrisolve™ Absorbable Punctum Plugs are available in two diameters: 0.4mm and 0.5mm. The implants are supplied sterile with two implants per package.

Absorption time for the Comfortear® Lacrisolve™ Absorbable Punctum Plugs is approximately 6 months (=<6). For full prescribing information, visit

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc. is a privately held ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight. For more information on the company and its work, visit

For more information please call 888-424-1192 or email to

*PHOTO for media: .
*Caption: Comfortear® Lacrisolve™ Absorbable Punctum Plugs.

News Source:
For more information regarding this press release, please visit:
Like, Share, Save this press release:
  TWEET   SHARE   G+   PIN IT   STUMBLE   LinkedIn   Instapaper   Buffer

Shortlink to this press release:
The content of the above press release was provided by the “news source” (Paragon BioTeck, Inc.) or authorized agency, who is solely responsible for its accuracy. Send2Press® is the originating wire service for this story and content is Copr. © 2014 Paragon BioTeck, Inc. with newswire version Copr. © 2014 Send2Press (a service of Neotrope). All trademarks acknowledged.

Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
STORY READS for this single page only, as of Oct 25 2016:
[ count retired 8.4.16 ]

back to top
REFERENCES: Comfortear Lacrisolve, ophthalmic products, FDA 510(k) clearance, CE mark, ophthalmic products, biopharmaceutical and medical device company, news, press release from Paragon BioTeck, Inc., Nov 17, 2014, Devices and Research, Business, Pharma, Portland, Oregon, Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug